Global Commercial Execution with our partners in the Vaccine and IVD Industry

November 29, 2023

As part of our strategic focus on the Vaccine & IVD Industry, we’re delighted to announce new colleagues as part of our commercial team. We proudly welcome two dynamic individuals, each bringing a wealth of experience and passion from the clinical diagnostic industry to our organization:

Stuart McRoberts will be heading the Global Vaccine & IVD Industry Sales Division. Stuart comes with a proven track record as General Manager and Sales Leader in the IVD industry, and he joins us with extensive experience and a strong track record from Thermo Fisher Scientific, Sekisui, Phillips, Abbott, and more. We believe, Stuart’s leadership and industry experience makes him the ideal match to drive and execute our vaccine industry strategy.

Anna Engelund is appointed Head of Strategic Marketing, Reagents. Anna is a professional with a PhD in Neurobiology and an MSc in Biochemistry plus a rich background at Dako, Agilent, and Radiometer. Her expertise will be instrumental in aligning our commercial and portfolio strategy for continued success.

The extensive experience of Stuart and Anna will help us strengthen and accelerate how we commercially execute on serving the Vaccine & IVD Industry segment with our reagent portfolio to deliver on our strong ambition in this area.